CLINICAL_TRIALS
trial_result
· 2014-07-08
Clinical Trial Update: Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety [Phase 3]
Summary
A Phase 3 trial evaluated a herbal combination of Passiflora incarnata, Crataegus oxyacantha, and Salix alba for mild to moderate anxiety and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marjan Industria e Comercio ltda | Conditions: Anxiety Disorder | Phase 3 | Status: COMPLETED